Li‐Chung Chiu

Memorial Hospital of South Bend — United States

Medicine · Health Sciences

17h-index821citations69works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory Support and Mechanisms(29), Intensive Care Unit Cognitive Disorders(15), Lung Cancer Treatments and Mutations(12), Mechanical Circulatory Support Devices(11), Sepsis Diagnosis and Treatment(10)

Publications69 total

Clinical significance of anti-RP11 and anti-Ro52 antibodies in patients evaluated for systemic sclerosis: Associations with interstitial lung disease and pulmonary arterial hypertension
Joint Bone Spine·2025
Plasma phenylalanine is associated with hospital mortality in acute respiratory distress syndrome: a prospective metabolic profiling cohort study
European journal of medical research·2025· 1 citedOpen Access
Comparing Ventilator-displayed Rapid Shallow Breathing Index Values Versus Standard Measurement Techniques: A Bench Study
2025Open Access
Serum Nickel Concentrations in Patients Receiving Chronic Hemodialysis
Hemodialysis International·2025· 1 citedOpen Access
Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis
Oncology Letters·2025· 2 citedOpen Access
Ventilatory variables and computed tomography features in COVID-19 ARDS and non–COVID-19-related ARDS: a prospective observational cohort study
European journal of medical research·2025· 1 citedOpen Access
The Mechanical Power in Patients with Acute Respiratory Distress Syndrome Undergoing Prone Positioning Can Predict Mortality
Diagnostics·2025· 3 citedOpen Access
Ventilatory variables and computed tomography features in COVID-19 ARDS and non– COVID-19-related ARDS: A prospective observational cohort study
2024Open Access
Evaluating the Efficacy of Inhaled Colistin via Two Nebulizer Types in Ventilator-Associated Pneumonia: Prospective Randomized Trial
Antibiotics·2024· 3 citedOpen Access
Late Breaking Abstract - Engineering an AI-base mesh nebulizer system for personalized respiratory drug delivery.
2024· 1 cited
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
Vaccines·2024· 3 citedOpen Access
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study
Environmental Health·2024· 3 citedOpen Access
A Real-World Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive Stage Small Cell Lung Cancer
Research Square (Research Square)·2024Open Access
Predictors of Mortality in Critically Ill Patients with Blood-stream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Research Square (Research Square)·2024Open Access
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer
Thoracic Cancer·2024· 2 citedOpen Access
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study
Research Square (Research Square)·2023· 2 citedOpen Access
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors
Frontiers in Oncology·2023· 1 citedOpen Access
Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review
Frontiers in Immunology·2023· 7 citedOpen Access
Predicting Inhaled Drug Dose Generated by Mesh Nebulizers
Journal of Aerosol Medicine and Pulmonary Drug Delivery·2023
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan
Targeted Oncology·2023· 25 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Kuo‐Chin Kao(27), Chung-Chi Huang(20), Han‐Chung Hu(19), Cheng‐Ta Yang(19), Chung-Shu Lee(14), Ping‐Chih Hsu(14), Chih-Hao Chang(13), Chih‐Hsi S. Kuo(13), Li‐Pang Chuang(12), Chen‐Yiu Hung(11), Shih‐Wei Lin(11), Hsin-Hsien Li(11), Shih‐Hong Li(9), Feng‐Chun Tsai(9), Huang-Pin Wu(9), Chin‐Chou Wang(9), Shaw‐Woei Leu(8), Shu‐Min Lin(8), Chih‐Wei Wang(7), Li‐Fu Li(7)